Articles Posted in Dangerous Products

There has been a huge uptick in the demand for weight loss drugs and as a result of new drug approvals, the supply has been impacted. Last fall, the drug manufacturer Eli Lilly received approval from the Food and Drug Administration (FDA) for a new medication for chronic weight management. The drug is known as Zepbound, and at $1059.87 for a month’s supply, it is cheaper than Wegovy, which is manufactured by Eli Lilly’s competitor Novo Nordisk. However, much of the excitement of Zepbound and Wegovy fails to appreciate the risks associated with these drugs. If you are a patient who has been harmed by Zepbound, you should call the seasoned dangerous drug Chicago-based attorneys of Moll Law Group. We represent people harmed around the country and billions have been recovered in lawsuits with which we’ve had involvement.

Consult Moll Law Group About Your Weight Loss Drug Lawsuit

The use of diabetes drugs for weight loss has gained increasing public attention. Initially, the FDA wouldn’t allow Eli Lilly to market the diabetes drug Mounjaro for obesity, but late last year, it approved Zepbound, which is based on the same active ingredient. You should be aware, however, that there still questions about long-term health risks of using these drugs.

Zepbound, or tirzepatide, is given as an injection for chronic weight management in patients that are obese or overweight with an additional weight-related condition. Around 70% of adults around the country are obese or overweight; being able to lose 5%-10% of their weight has been linked to a reduced danger of suffering cardiovascular disease. The same drug is marketed under the trade name Mounjaro for use by adults with type 2 diabetes mellitus to better their glucose levels. Mounjaro has been the subject of increasing numbers of product liability lawsuits brought by people who took the drug and allegedly experienced gallbladder and gastrointestinal complications necessitating further expensive medical treatment.

Continue reading →

Recently, the United States Foods and Drug Administration (FDA) issued a recall for Fresenius’ Ivenix Infusion System. Over 1,500 infusion pumps have been found susceptible to leaks and electrical failures that can result in the pump turning off during a treatment that is normally lifesaving. These systems may be defective. If you were injured or a loved one died and you believe it was the result of an Ivenix infusion defect, you should call the seasoned Chicago-based product liability lawyers of Moll Law Group. We represent injured consumers nationwide. Billions have been recovered in lawsuits with which we’ve been involved.

Call Moll Law Group About Whether You Have an Infusion Lawsuit

The recalled system is a high-volume pump that hospital staff use to provide a patient with specific amounts of fluid to their veins, or beneath their skin, or in their spine. Patients who receive this care include adults, infants, children, teens, and neonates. The danger addressed by the recall is that the pump can leak fluids from the pump into what’s called the Administration Set Loading Area of the infusion system.

This poses a serious danger because that area is located by the Air detector, and when fluid hits the electrical parts of the infusion pump, it may go through an electrical short that leads the device to power down with so warning. There have been 14 reports arising out of this issue. No deaths were reported as of this writing, but officials have warned that delay of infusions to children who need them could cause serious injuries or deaths.

Continue reading →

In an ongoing investigation against Goodyear Tire & Rubber Co., the company is in the hot seat for how it has handled the recall of a product it stopped manufacturing in 2003. The product is a specific model of tire that has been used primarily on motor homes, and that has been found defective under certain conditions. When the tire is placed on a heavy RV or is not properly inflated, the tread can separate and ultimately cause injuries for consumers. So far, the tire has been linked to eight deaths and 69 injuries. On top of these figures, there have also been approximately 600 reports of property damage due to the tire’s possible defects.

Because the company stopped manufacturing the product almost 20 years ago, most of the tires are no longer in use. However, in early 2022, the National Highway Traffic Safety Administration released a statement recalling the 173,000 tires that could have possibly still been on the road. Now, the U.S. Justice Department is investigating the company for its response to the tire recall.

Apparently, the Justice Department has been asking for Goodyear records, reports, depositions, and other documents that might be relevant to the investigation. Goodyear claims that it has turned over everything the Justice Department has asked for and that it will continue to cooperate. To further complicate things, the company recently released a statement alleging the tire line was not defective at all. There is no active issue, said Goodyear, since the company has not received an injury report in over 14 years related to this tire.

Still, investigators want to make sure that consumers using this tire are aware of the risks and are well-protected. Oftentimes, a tire recall happens in an abundance of caution and as a preventative measure. Just because a product is recalled does not mean that the manufacturing company is actually liable for the injuries that have been reported. An investigation is required, and the claims must be carefully reviewed and studied. If the investigation determines that the manufacturing company is responsible for the injuries, consumers may be entitled to compensation as a result.

Continue reading →